Envirotech adds medical supplies, drones; hits $10M goodwill impairment, big losses

Envirotech Vehicles, Inc. (NASDAQ: ADOM) - quick read on what's happening inside

Snapshot - the numbers that matter
- Sales (3 months ended 6/30/2025): $1,047,029 vs $812,770 a year ago.
- Sales (6 months): $1,637,595 vs $1,623,260 a year ago.
- Cost of sales (3 months): $2,504,746 → Gross loss $(1,457,717).
- Cost of sales (6 months): $2,975,921 → Gross loss $(1,338,326).
- Net loss (3 months): $(5,146,737). Net loss (6 months): $(19,183,118).
- Net loss per share (basic & diluted): $(2.01) (quarter); $(8.10) (six months).
- Weighted average shares: 2,556,204 (Q); 2,369,404 (6M). Outstanding shares reported: 3,220,058 (6/30/2025) and 3,530,546 (as of 8/12/2025).
- Cash and cash equivalents (6/30/2025): $942,241. Ending working capital ≈ negative $120,030 (company statement).
- Total assets fell to $22,744,082 from $32,671,302 (12/31/2024) largely after a $10,103,048 goodwill impairment.
- Total liabilities: $16,836,671; stockholders' equity: $5,907,411 (6/30/2025).

What's happening inside the business - operational and structural moves
- The company expanded into two new segments in 2025: medical supplies and drones (in addition to electric vehicles).
- Opened a new 86,000 sq ft facility / HQ in Houston (relocation announced Feb 12, 2025). Investment and capitalization of lease ROU assets present on the balance sheet.
- Pursuing manufacturing footprint in Osceola, Arkansas (purchase subject to final closing).
- Significant financing activity under an A&R SEPA with a large investor: additional promissory notes of $4.75M (net proceeds) in 2025, many notes converted into stock during the period.
- Corporate actions to address Nasdaq minimum bid price: received a deficiency notice (March 6, 2025) and effected a 1-for-10 reverse stock split (effective Aug 6-8, 2025) as a remediation step.

Positive items
- Revenue was roughly flat year-to-date and up quarter-over-quarter (Q vs Q). Medical supplies produced meaningful revenue quickly: $1,072,266 in the quarter and $1,289,532 for six months (but to a related party).
- Company secured near-term liquidity through convertible/promissory financings (net ~$4.75M raised in 2025 financing tranche).
- CapEx and property & equipment increased (net PPE $1.97M vs $592k at 12/31/2024) showing investment in production (electric buses and facilities).
- Non-cash items cleared the balance sheet: goodwill impaired ($10.103M) - removes future amortization/uncertainty related to that carrying value.

Negative items / risks visible from the income statement and notes
- Large operating losses: $5.15M loss in the quarter and $19.18M for six months - driven by high operating expenses and significant non-cash charges.
- Cost of sales far exceeded revenue in the periods reported - inventory write-downs and large vehicle cost recognition increased COGS (company disclosed inventory write-down of $1,172,302 included in six-month COGS).
- Goodwill impairment: $10,103,048 non-cash charge in Q1 2025 - indicates prior acquisition goodwill is not recoverable under current valuations.
- Heavy reliance on concentrated customers and related parties: medical supplies revenue for these periods came 100% from a related party; five customers = ~93% of EV receivables. That concentration increases collection and revenue risk.
- Inventory deposits concentrated: three vendors account for 100% of inventory deposits (supply-concentration risk).
- Negative working capital and low cash balance ($942k) while future debt/lease payments and capex exist. Operating cash used (6M): $(5,385,357); financing provided ~$4.56M - cash burn remains a concern.
- Fair-value losses and conversion losses on financing instruments: unrealized loss on financial instruments $(573,937) (6M) and realized loss on conversions of notes $76,764 - volatility tied to equity price and complex financing structures.
- Material weakness in internal controls (segregation of duties) disclosed - increases risk of accounting errors and external audit qualifications if not remediated.
- Nasdaq compliance risk (minimum bid price) required a reverse split - an indicator of weak market liquidity/valuation and potential dilution pressure.
- Ongoing litigation (GreenPower cases) and related-party transactions raise governance and contingent liability concerns.

Key balance-sheet and cashflow stats to watch
- Cash: $942,241 (6/30/2025).
- Accounts receivable, net: $440,292 (allowance $406,690).
- Receivable from related party (medical supplies): $2,155,247 (allowance $40,633).
- Inventory, net: $4,855,679 with inventory valuation allowance $1,184,731; inventory deposits: $7,465,129 (3 vendors = 100%).
- Deferred revenue: $6,525,081 (increased vs. 12/31/2024).
- Debt (current): $5,365,276; total future scheduled debt payments disclosed: $4,942,544 (remainder 2025 and 2026).
- Stock-based dilution: 977,250 options outstanding (944,026 exercisable) and 147,039 warrants outstanding; significant note conversions issued large share blocks during the period (e.g., 853,275 shares from one conversion event).

What to monitor next (near-term catalysts & red flags)
- Ability to convert deferred revenue and to collect receivables (especially related-party balances).
- Inventory turn and further valuation adjustments - additional write-downs would hit gross margin and cash flow.
- Execution at the Houston facility and any finalization of the Osceola property purchase - capital needs and timing matter.
- Outcome of Nasdaq compliance path post-reverse split (sustained $1+ bid requirement).
- Financing runway: if operating cash burn continues, the company is dependent on SEPA/convertible financings which have dilution and price-floor mechanics.
- Resolution of material control weaknesses and any material legal outcomes (GreenPower litigation).

Bottom line: Envirotech Vehicles, Inc. (NASDAQ: ADOM) is actively expanding operations (medical supplies, drones, new Houston HQ, production investment) and has raised near-term financing, but the business is loss-making, faces heavy inventory and receivable concentration, reported a large non-cash goodwill impairment, and is burning cash. The balance sheet shows limited liquidity and reliance on external financings; governance and control issues and Nasdaq compliance pressure add execution risk. Investors should watch cash burn, collection of large related-party receivables, inventory recoverability, and any further dilution from financing conversions.